gefitinib has been researched along with mitoxantrone hydrochloride in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (mitoxantrone hydrochloride) | Trials (mitoxantrone hydrochloride) | Recent Studies (post-2010) (mitoxantrone hydrochloride) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 23 | 0 | 17 |
| Protein | Taxonomy | gefitinib (IC50) | mitoxantrone hydrochloride (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 0.0509 | |
| DNA-(apurinic or apyrimidinic site) endonuclease | Homo sapiens (human) | 2 | |
| DNA-3-methyladenine glycosylase | Homo sapiens (human) | 2.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
1 other study(ies) available for gefitinib and mitoxantrone hydrochloride
| Article | Year |
|---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |